Issued Patents 2022
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11512083 | Compounds and methods for the enhanced degradation of targeted proteins | Andrew P. Crew, Craig M. Crews, Hanqing Dong, Caterina Ferraro, Yimin Qian +5 more | 2022-11-29 |
| 11485742 | 2-azaspiro[3.4]octane derivatives as M4 agonists | Amy Calhoun, Kevin Matthew Gardinier, Edward Charles Hall, Keith Jendza, Nancy LABBE-GIGUERE +7 more | 2022-11-01 |
| 11427548 | Compounds and methods for the targeted degradation of androgen receptor | Andrew P. Crew, Hanqing Dong, Jing Wang, Yimin Qian, Kurt Zimmermann +2 more | 2022-08-30 |
| 11389480 | Human monoclonal antibody targeting TNFR2 for cancer immunotherapy | Joost Oppenheim, Dimiter S. Dimitrov, De Yang, Zhongyu Zhu | 2022-07-19 |
| 11352351 | Compounds and methods for the targeted degradation of androgen receptor | Meizhong Jin, Andrew P. Crew, Hanqing Dong, Jing Wang, Yimin Qian | 2022-06-07 |
| 11278524 | Formulations and methods for the treatment of cancers | Dean G. Tang | 2022-03-22 |
| 11266673 | Nucleotide derivatives and methods of use thereof | Jingyue Ju, Xiaoxu Li, Zengmin Li, Min-Kang Hsieh, Minchen Chien +8 more | 2022-03-08 |